Invests in A B U N D A N C E !
ISIS Investment Franchises

Biomedical Technology Transfer International (BTTI)

It takes an average of $150 million and 10-15 years to successfully develop and manufacture a pharmaceutical drug.  It is our intent to revolutionize this industry through the use of all natural Egyptian Health Spa alternative healthcare treatment centers.

BTTI plans to develop our treatment therapies for 10% of the cost in 10% - 20% of the time with NO side effects, with non-invasive technology, and with 50% - 100% success rates, depending on the treatment of early stages of the diseases.

BTTI intends to capture a significant amount of the healthcare and elderly care market within our first ten years of operations.  Given that the current market size for all pharmaceutical/biomedical/biotech/healthcare/elderly care and all other types of current medical treatments existing or in development, within franchises, we intend to support an estimated $36 Billion dollar market over the next 10 years.






Progress